Keyphrases
Sheehan Disability Scale
100%
Obsessive-compulsive Disorder
100%
Treatment Response
100%
Quality of Life Outcomes
100%
Treatment-related Symptoms
100%
Health-related Quality of Life
83%
Escitalopram
83%
Non-responders
50%
Short Form 36 (SF-36)
50%
SF-36 Score
50%
Relapser
33%
Prevention Trials
33%
Relapse Prevention
33%
Paroxetine
33%
Placebo-controlled
33%
Disability
33%
Fixed-dose Combination
33%
Placebo
16%
Impairment in Functioning
16%
Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)
16%
Double-blind Placebo-controlled Trial
16%
Work-related
16%
Baseline Data
16%
Flexible Dose
16%
Symptomatic Outcome
16%
Bodily Pain
16%
Functional Impairment
16%
Obsessive-compulsive Disorder Symptoms
16%
Functional Outcome
16%
Response-outcome
16%
Functional Disability
16%
Treatment Group
16%
Treatment Outcome
16%
Disability Health
16%
Medical Outcomes Study
16%
DSM-IV
16%
Medicine and Dentistry
Short Form 36
100%
Treatment Response
100%
Obsessive Compulsive Disorder
100%
Quality of Life
100%
Sheehan Disability Scale
100%
Escitalopram
83%
Placebo
66%
Paroxetine
33%
Relapse Prevention
33%
Yale-Brown Obsessive Compulsive Scale
16%
Obsessive-Compulsive Disorder Symptoms
16%
DSM-IV
16%
Neuroscience
Obsessive-Compulsive Disorder
100%
Escitalopram
100%
Placebo
80%
Paroxetine
40%
Relapse Prevention
40%
Obsessive-Compulsive Disorder Symptoms
20%
Psychology
Obsessive-Compulsive Disorder
100%
Quality of Life
100%
Relapse Prevention
33%
Obsessive-Compulsive Disorder Symptoms
16%